Results 31 to 40 of about 7,681 (214)
Comparison of clinical efficacy and safety between indacaterol and tiotropium in COPD: meta-analysis of randomized controlled trials. [PDF]
PLoS ONE, 2015 Two once-daily inhaled bronchodilators, indacaterol and tiotropium, are widely used as first-line therapy in stable COPD patients. This study was performed to compare the clinical efficacy and safety between indacaterol and tiotropium in patients with ...
Jung Soo Kim +10 more
doaj +1 more source
, 2012 BackgroundLong-acting bronchodilators comprising long-acting beta(2)-agonists and the anticholinergic agent tiotropium are commonly used for managing persistent symptoms of chronic obstructive pulmonary disease.
Christopher J Cates +3 more
core +1 more source
, 2011 Background The long-acting bronchodilator tiotropium and single inhaler combination therapy of inhaled corticosteroids and long-acting beta(2)-agonists are both commonly used for maintenance treatment of chronic obstructive pulmonary disease.
Christopher J Cates +3 more
core +1 more source
Formoterol and Tiotropium Compared With Tiotropium Alone for Treatment of COPD
COPD: Journal of Chronic Obstructive Pulmonary Disease, 2009 Combined use of beta(2)-agonists and anticholinergic bronchodilators may have complementary benefits in patients with chronic obstructive pulmonary disease (COPD). The objective of this study was to compare combination treatment with formoterol (FORM) plus tiotropium (TIO) versus treatment with TIO alone in patients with COPD. In this active-controlled,
Donald P, Tashkin +3 more
openaire +2 more sources
Low Dose Theophylline and Tiotropium Rotacap as Add on Therapy in COPD Patients-Clinical Trial
Journal of Bahria University Medical and Dental College, 2021 Objectives: To compare the role of low dose Theophylline and Tiotropium rotacap in improving the lung functions and day to day life of patients suffering from COPD.
Muzna Hameed Dar +4 more
doaj +1 more source
, 2011 BackgroundLong-acting bronchodilators comprising long-acting beta(2)-agonists and the anticholinergic agent tiotropiumare commonly used, either on their own or in combination, for managing persistent symptoms of chronic obstructive pulmonary disease ...
Christopher J Cates +3 more
core +1 more source
Tiotropium Bromide: An Update [PDF]
The Open Respiratory Medicine Journal, 2009 Tiotropium bromide is a once-daily inhaled anticholinergic bronchodilator. It works by blocking the muscarinic receptors in airway smooth muscle. Tiotropium has a wide therapeutic margin, due to its poor gastrointestinal absorption and its very low systemic bioavailability. The drug is mainly indicated in COPD patients.
openaire +2 more sources
Tiotropium in children and adolescents with asthma [PDF]
Annals of Allergy, Asthma & Immunology, 2020 Asthma is a major cause of morbidity in children, despite the availability of various treatments. In adults, tiotropium-a long-acting muscarinic antagonist-as add-on therapy to an inhaled corticosteroid with or without a long-acting β2-agonist provides clinical benefit with a safety profile similar to placebo.To review published evidence on the ...
Kevin R, Murphy, Bradley E, Chipps
openaire +2 more sources
, 2010 Background Combination therapy (inhaled corticosteroids and long-acting beta(2)-agonists) and tiotropium are both used in the treatment of chronic obstructive pulmonary disease (COPD).
Christopher J Cates +5 more
core +1 more source
Tiotropium in paediatric asthma [PDF]
European Respiratory Journal, 2017 No significant benefit of inhaled tiotropium was found in a trial in children and young people with severe asthmahttp://ow.ly ...
openaire +3 more sources